{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:31:48Z","timestamp":1789007508417,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.acvd.2020.05.017","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T19:02:50Z","timestamp":1600196570000},"page":"679-689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Patients with acute heart failure treated with the CARRESS-HF diuretic protocol in association with canrenoate potassium: Tolerance of high doses of canrenoate potassium"],"prefix":"10.1016","volume":"113","author":[{"given":"Clothilde","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Prieur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bochaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Berthiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles-Edouard","family":"Luyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bonnefoy-Cudraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2020.05.017_bib0145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IJNRD.S135660","article-title":"Combined aquaretic and diuretic therapy in acute heart failure","volume":"10","author":"Goyfman","year":"2017","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.acvd.2020.05.017_bib0150","first-page":"1794","article-title":"Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial","volume":"69","author":"Salahudin","year":"2019","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.acvd.2020.05.017_bib0155","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.CIR.100.12.1311","article-title":"Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction","volume":"100","author":"Cooper","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2020.05.017_bib0160","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/01.CIR.98.15.1510","article-title":"Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart)","volume":"98","author":"Nolan","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2020.05.017_bib0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jacc.2003.06.021","article-title":"What is the optimal serum potassium level in cardiovascular patients?","volume":"43","author":"Macdonald","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2020.05.017_bib0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1440-1681.1985.tb02317.x","article-title":"Stability and inter-relationships of hormone, haemodynamic and electrolyte levels in heart failure in man","volume":"12","author":"Fitzpatrick","year":"1985","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.acvd.2020.05.017_bib0175","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/hrt.42.3.316","article-title":"Relation of plasma aldosterone concentration to diuretic treatment in patients with severe heart disease","volume":"42","author":"Knight","year":"1979","journal-title":"Br Heart J"},{"key":"10.1016\/j.acvd.2020.05.017_bib0180","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.semnephrol.2011.09.009","article-title":"Metabolic complications associated with use of diuretics","volume":"31","author":"Palmer","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.acvd.2020.05.017_bib0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchf.2014.09.003","article-title":"Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure","volume":"3","author":"Mentz","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.acvd.2020.05.017_bib0190","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF Randomized Clinical Trial","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.acvd.2020.05.017_bib0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0014-2999(82)90175-3","article-title":"Detection and comparative evaluation of aldosterone antagonists in glucocorticoid-treated, adrenalectomized rats","volume":"80","author":"Casals-Stenzel","year":"1982","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.acvd.2020.05.017_bib0200","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7326\/0003-4819-102-3-314","article-title":"Furosemide absorption altered in decompensated congestive heart failure","volume":"102","author":"Vasko","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acvd.2020.05.017_bib0205","series-title":"SOLUDACTONE 200mg, lyophilisat et solution pour usage parent\u00e9ral\u00a0\u2013\u00a0R\u00e9sum\u00e9 des caract\u00e9ristiques du produit","author":"ANSM","year":"2019"},{"key":"10.1016\/j.acvd.2020.05.017_bib0210","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2020.05.017_bib0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2020.05.017_bib0220","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/j.1552-4604.1989.tb03339.x","article-title":"Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolites","volume":"29","author":"Gardiner","year":"1989","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.acvd.2020.05.017_bib0225","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000001770","article-title":"KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors","volume":"101","author":"Lentine","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.acvd.2020.05.017_bib0230","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2020.05.017_bib0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2017.03.011","article-title":"True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: a meta-analysis","volume":"188","author":"Vukadinovic","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2020.05.017_bib0240","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cardfail.2017.04.014","volume":"23","author":"Yancy","year":"2017","journal-title":"J Card Fail"},{"key":"10.1016\/j.acvd.2020.05.017_bib0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2020.05.017_bib0250","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.recesp.2011.06.013","article-title":"[Aldosterone receptor antagonist use after myocardial infarction. Data from the REICIAM registry]","volume":"64","author":"Lopez-de-Sa","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.acvd.2020.05.017_bib0255","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2020.05.017_bib0260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacc.2012.08.1019","article-title":"Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction","volume":"61","author":"Rassi","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2020.05.017_bib0265","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-0676.1993.tb00624.x","article-title":"Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content","volume":"13","author":"Bernardi","year":"1993","journal-title":"Liver"},{"key":"10.1016\/j.acvd.2020.05.017_bib0270","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1677\/joe.0.0530425","article-title":"Urinary excretion of sodium and potassium in relation to plasma aldosterone concentration","volume":"53","author":"Adamson","year":"1972","journal-title":"J Endocrinol"},{"key":"10.1016\/j.acvd.2020.05.017_bib0275","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1113\/jphysiol.1961.sp006684","article-title":"The effects of intravenous aldosterone and hydrocortisone on the urinary electrolytes of the recumbent human subject","volume":"156","author":"Mills","year":"1961","journal-title":"J Physiol"},{"key":"10.1016\/j.acvd.2020.05.017_bib0280","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/pgmj.53.617.117","article-title":"The urinary sodium: potassium ratio and response to diuretics in resistant oedema","volume":"53","author":"Alexander","year":"1977","journal-title":"Postgrad Med J"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213620301820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213620301820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:46:22Z","timestamp":1761745582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213620301820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1875213620301820"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2020.05.017","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients with acute heart failure treated with the CARRESS-HF diuretic protocol in association with canrenoate potassium: Tolerance of high doses of canrenoate potassium","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2020.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}